Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rola Ali S. Alotabi"'
Autor:
Yazeed Ali S. Albalawi, Zahraa Abbas A. Kassarah Al-nakhli, Turki Abdullah A. Alzahrani, Hassan Ahmed A. Arishi, AlTurki Abdulrahman Mohammed, Naif Abdullah M. Alzahrani, Abdulrahim Oudah A. Albalawi, Nada Saleem S. alhawiti, Rola Ali S. Alotabi, Musab Ismail Y. Ezzi, Sultan Suliman Q. Al-Ruwaili, Muflih Abdullah S. Albalawi, Mohammed H. Abushal, Abdalah Emad Almhmd, Amal Sulaiman A. Al-Balawi
Publikováno v:
Journal of Pharmaceutical Research International. :235-241
Bacterial arthritis is an inflammation of the joints caused by an infectious etiology, usually bacterial, but there are also fungi, mycobacteria, viruses, or other rare pathogens. Both healthy and predisposed people can be infected. Nongonococcal inf
Autor:
Waad Ali Alkaabneh, Abdullah Ibrahim Altidlawi, Ruby Naif M. Alsubaie, Amal Nafea J. Alharbi, Abdulrahman Arshed N. Alharfy, Rola Ali S. Alotabi, Afnan Mohammed H. Almutairi, Amani Ahmad S. Albalawi, Marwan Saleh D. Albalawi, Abdulmajeed Mousa Alzahrani
Publikováno v:
Journal of Pharmaceutical Research International. :215-221
Neovascular glaucoma (NVG) is an aggressive type of glaucoma, which often results in poor visual outcomes. Antivascular endothelial growth factor is frequently used for various conditions in which VEGF release is induced in response to retinal ischem
Autor:
Ibrahim Mahmoud H. Ajwah, Raghad Saud A. Albalawi, Rola Ali S. Alotabi, Maram Atallah M. Albalawi, Sarah Muqbil B. Altmimi, Sarah Fahad M. Bukhari, Amal Sulaiman A. Al-Balawi, Raghad Fraih A. Al-Balawi, Shahad Suliman H. Aljuhani, Nouf Obaidullah M. Alenazi, Abdulaziz Saed A. Albalawi, Faisal Shiraz M. Alharthi, Reham Hamid AlRuhil, Abdulaziz Saeed A. Alghamdi, Lama Akram A. Alanazi, Wejdan Hlel Al-Atawi
Publikováno v:
International Journal of Medicine in Developing Countries. :2351-2356
Hepatorenal syndrome (HRS) is a potentially reversible clinical syndrome in which a functional renal failure occurs in end-stage liver disease cases. It is a fatal complication of advanced cirrhosis with ascites and liver failure, with nearly 50% of